Skip Navigation LinksHome > February 2012 - Volume 112 - Issue 2 > First Combination Drug for Type 2 Diabetes and Hyperlipidemi...
AJN, American Journal of Nursing:
doi: 10.1097/01.NAJ.0000411172.23319.c3
Drug Watch

First Combination Drug for Type 2 Diabetes and Hyperlipidemia

Aschenbrenner, Diane S. MS, RN

Collapse Box

Abstract

* Juvisync is the first approved fixed-dose combination drug to treat type 2 diabetes and hyperlipidemia. It combines the anti-hyperglycemic drug sitagliptin (Januvia) with the antilipid drug simvastatin (Zocor).

* Various dose combinations will be available.

© 2012 Lippincott Williams & Wilkins, Inc.

Login